January 24, 2022 in Kineta Press Release

Kineta to Present on the Company’s Platform at the 6th Annual Tumor Models for Immuno-oncology Summit

Seattle, WA — (January 24, 2022) Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today an upcoming presentation at the 6 ...

Read More